Skip to search.
 FTSE 100 Down 0.11%
Streaming
Ticker Tape: On

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
152.23 Down 3.87(2.48%) 23 Apr 21:00
|After Hours: : 157.35 Up 5.12 (3.36%) 00:59
Add to Portfolio
Prev Close:156.10
Open:155.97
Bid:147.75 x 100
Ask:157.60 x 100
1y Target Est:190.95
Beta:0.51
Next Earnings Date:24-Apr-14ALXN Earnings announcement
Day's Range:150.21 - 156.98
52wk Range:87.01 - 185.43
Volume:1,353,899
Avg Vol (3m):1,954,670
Market Cap:30.12b
P/E (ttm):119.87
EPS (ttm):1.27
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALXNDown 2.48%30.12b
AMGNDown 5.02%85.55b
BAXDown 0.19%39.24b

Key Statistics

Forward P/E (1 yr):28.30
P/S (ttm):19.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :4.49
Quarterly EPS Est (Mar-14) :1.26
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback